Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.20.4
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Cash Flows From Operating Activities:    
Net loss $ (8,146,909) $ (4,322,370)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 276,582 220,384
Issuance of common stock for services   100,000
Amortization of operating lease right-of-use asset 39,671 34,569
Depreciation 153 177
Changes in operating assets and liabilities:    
Prepaid expenses (1,161,066) (7,636)
Deposits 19,031
Accounts payable (872,060) (1,166,281)
Accrued expenses 88,442 (37,107)
Accrued compensation 225,875 75,295
Accrued interest 3,968 3,991
Operating lease liability (38,272) (15,282)
Net Cash Used In Operating Activities (9,564,585) (5,114,260)
Cash Flows From Financing Activities:    
Proceeds from sale of NoveCite, Inc. common stock 500
Net proceeds from common stock warrant exercises 106
Net Cash Provided By Financing Activities 500 106
Net Change in Cash and Cash Equivalents (9,564,085) (5,114,154)
Cash and Cash Equivalents - Beginning of Period 13,859,748 7,893,804
Cash and Cash Equivalents - End of Period 4,295,663 2,779,650
Supplemental Disclosures Of Cash Flow Information and Non-cash Activities:    
Operating lease right-of-use asset and liability recorded upon adoption of ASC 842 $ 1,137,724